|
ETFB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.82839999998785E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.170800E-04 |
| Normal-vs-Stage2 |
8.39009999999973E-05 |
| Normal-vs-Stage3 |
3.79449999999837E-05 |
| Normal-vs-Stage4 |
2.429300E-04 |
| Stage1-vs-Stage2 |
1.951840E-01 |
| Stage1-vs-Stage3 |
8.022100E-02 |
| Stage1-vs-Stage4 |
2.137600E-01 |
| Stage2-vs-Stage3 |
9.405600E-01 |
| Stage2-vs-Stage4 |
7.297800E-01 |
| Stage3-vs-Stage4 |
6.750200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.98259999999851E-05 |
| Normal-vs-AfricanAmerican |
1.32289999998925E-06 |
| Normal-vs-Asian |
2.315600E-02 |
| Caucasian-vs-AfricanAmerican |
7.730000E-02 |
| Caucasian-vs-Asian |
7.690600E-01 |
| AfricanAmerican-vs-Asian |
7.380800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25090000000039E-05 |
| Normal-vs-Female |
1.39499999995962E-06 |
| Male-vs-Female |
1.449620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.86179999999548E-05 |
| Normal-vs-Extreme_Weight |
1.115500E-03 |
| Normal-vs-Obese |
1.780950E-04 |
| Normal-vs-Extreme_Obese |
3.773900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.205400E-01 |
| Normal_Weight-vs-Obese |
5.365000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.790800E-01 |
| Extreme_Weight-vs-Obese |
5.083600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.304200E-01 |
| Obese-vs-Extreme_Obese |
6.543000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.21499999639863E-08 |
| Normal-vs-Age(61-80Yrs) |
4.565800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.18300000000005E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.328400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.490800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.780400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.663600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.666400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.337160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.212300E-04 |
| Normal-VS-Type2 PRCC |
1.136510E-03 |
| Normal-VS-KIRP CIMP |
2.83879999951608E-07 |
| Normal-VS-Unclassified PRCC |
3.8436000004971E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.671600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.187080E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.055700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.249000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.363700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.330650E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.343770E-03 |
| Normal-vs-N1 |
1.34460000000836E-06 |
| Normal-vs-N2 |
3.184700E-03 |
| N0-vs-N1 |
1.224010E-01 |
| N0-vs-N2 |
3.853200E-01 |
| N1-vs-N2 |
8.206800E-01 |
|
|
